Pfizer explores sale of hospital drugs unit, sources say
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in ...
Pfizer (PFE) has been on a downward spiral lately with significant selling pressure. After declining 11% over the past four ...
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
On Friday, Pfizer Inc (PFE) stock saw a decline, ending the day at $26.72 which represents a decrease of $-0.74 or -2.69% from the prior close of $27.46. The stock opened at $27.11 and touched a low ...
Pfizer (PFE) is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, Reuters’ ...
Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.
Pfizer's stock underperforms the S&P 500, facing patent expirations and competition, yet offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker ...
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback